BeOne Medicines (BEIGF) Enterprise Value (2015 - 2026)
BeOne Medicines (BEIGF) reported Enterprise Value of -$4.8 billion for Q1 2026, down 90.42% year-over-year from -$50.0 billion in Q1 2025, and down 5.37% quarter-over-quarter from -$4.5 billion in Q4 2025.
BeOne Medicines (BEIGF) Enterprise Value (2015 - 2026) Analysis & Trends
BeOne Medicines (BEIGF) has 12 years of Enterprise Value data on file, last reported at -$4.8 billion in Q1 2026.
- Enterprise Value for Q1 2026 came in at -$4.8 billion, down 90.42% year-over-year; the trailing twelve-month figure through Mar 2026 was -$4.8 billion (down 90.42% YoY), and the FY2025 annual result was -$4.5 billion, down 73.08% from the prior year.
- Enterprise Value slipped to -$4.8 billion in Q1 2026 per BEIGF's latest filing, from -$4.5 billion in the prior quarter.
- Over five years, Enterprise Value peaked at -$872.2 million in Q3 2022 and troughed at -$5.7 billion in Q2 2022.
- A 5-year average of -$3.3 billion and a median of -$3.2 billion in 2023 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2022 and 2023: Enterprise Value surged 77.73% in 2022, then sank 263.95% in 2023.
- A 5-year view of Enterprise Value shows it stood at -$4.5 billion in 2022, then increased by 30.0% to -$3.2 billion in 2023, then gained by 17.23% to -$2.6 billion in 2024, then slumped by 73.08% to -$4.5 billion in 2025, then dropped by 5.37% to -$4.8 billion in 2026.
- Business Quant data shows BEIGF's Enterprise Value at -$4.8 billion in Q1 2026, -$4.5 billion in Q4 2025, and -$4.0 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 821,726.73 Bn | 821,726.69 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 57,768.00 Bn | 57,768.00 Bn | - | - |
| 3 | Quantum Biopharma | 16,655.88 Bn | 16,655.88 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 3,540.00 Bn | 3,539.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Evaxion A | 1,526.26 Bn | 1,526.24 Bn | - | -18.44 Mn |
| 6 | Akari Therapeutics | 1,520.09 Bn | 1,520.09 Bn | - | -2.77 Mn |
| 7 | Psyence Biomedical | 223.87 Bn | 223.87 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 114.47 Bn | 107.23 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 91.22 Bn | 91.22 Bn | - | -584.73 Mn |
| 10 | BeOne Medicines | - | - | 1.35 Bn | -4.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.79 Bn |
| Dec 31, 2025 | -4.55 Bn |
| Sep 30, 2025 | -4.04 Bn |
| Jun 30, 2025 | -2.76 Bn |
| Mar 31, 2025 | -2.52 Bn |
| Dec 31, 2024 | -2.63 Bn |
| Sep 30, 2024 | -2.70 Bn |
| Jun 30, 2024 | -2.59 Bn |
| Mar 31, 2024 | -2.79 Bn |
| Dec 31, 2023 | -3.17 Bn |
| Sep 30, 2023 | -3.17 Bn |
| Jun 30, 2023 | -3.52 Bn |
| Mar 31, 2023 | -3.83 Bn |
| Dec 31, 2022 | -4.53 Bn |
| Sep 30, 2022 | -872.19 Mn |
| Jun 30, 2022 | -5.70 Bn |
| Mar 31, 2022 | -1.90 Bn |
| Dec 31, 2021 | -2.24 Bn |
| Sep 30, 2021 | -3.92 Bn |
| Jun 30, 2021 | -4.38 Bn |